{"id":{"repo_id":"radboud","oai_identifier":"oai:repository.ubn.ru.nl:2066/329120"},"canonical_url":"https://search.dev.ndltd.org/etd/radboud/oai:repository.ubn.ru.nl:2066/329120","repository":{"repo_id":"radboud","name":"Radboud University Nijmegen","base_url":"https://repository.ubn.ru.nl/oai/request"},"display":{"title":"Personalizing tricyclic antidepressant treatment for major depressive disorder","abstract":"Contains fulltext : 329120.pdf (Publisher’s version ) (Closed access)","abstract_html":"Contains fulltext : 329120.pdf (Publisher’s version ) (Closed access)","abstract_has_math":false,"creators":["Vos, C.F."],"institution":"S.l. : s.n.","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Schellekens, A.F.A.","Aarnoutse, R.E.","Janzing, J.G.E.","Coenen, M.J.H."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-07-24T04:03:13Z","subjects":["Donders Series","Psychiatry - Radboud University Medical Center - DCMN"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["9789462843370","Donders Series ; 783,"],"render_values":[{"text":"9789462843370","href":null,"code":true},{"text":"Donders Series ; 783,","href":null,"code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/2066/329120","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Schellekens, A.F.A.","Aarnoutse, R.E.","Janzing, J.G.E.","Coenen, M.J.H."]},{"key":"dc:creator","label":"Author","values":["Vos, C.F."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:publisher","label":"Institution","values":["S.l. : s.n."]},{"key":"dc:type","label":"Dc Type","values":["Doctoral thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Donders Series","Psychiatry - Radboud University Medical Center - DCMN"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://hdl.handle.net/2066/329120","9789462843370","Donders Series ; 783,"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Contains fulltext : 329120.pdf (Publisher’s version ) (Closed access)","In the treatment of depression with antidepressants, effectiveness varies widely between patients and adverse effects are common. This thesis shows that a more personalized approach to tricyclic antidepressant (TCA) treatment can improve clinical outcomes. The findings demonstrate substantial variation in current prescribing and dosing practices. Personalized dosing strategies, such as dosing guided by genetic characteristics or early plasma concentrations, enable faster attainment of therapeutic doses and are associated with fewer adverse effects. In addition, specific pharmacological characteristics, including the ratio between active metabolites, are linked to improved effectiveness and tolerability. Early clinical signals, such as improvement in sleep during the first weeks of treatment, also predict later treatment response. Together, these results indicate that tailoring antidepressant treatment to the individual patient can make depression treatment safer and more effective.","Radboud University, 23 maart 2026","Promotores : Schellekens, A.F.A., Aarnoutse, R.E. Co-promotores : Janzing, J.G.E., Coenen, M.J.H.","231 p."]},{"key":"dc:title","label":"Title","values":["Personalizing tricyclic antidepressant treatment for major depressive disorder"]}]}],"canonical_facts":{"dc:contributor":["Schellekens, A.F.A.","Aarnoutse, R.E.","Janzing, J.G.E.","Coenen, M.J.H."],"dc:creator":["Vos, C.F."],"dc:date":["2026"],"dc:description":["Contains fulltext : 329120.pdf (Publisher’s version ) (Closed access)","In the treatment of depression with antidepressants, effectiveness varies widely between patients and adverse effects are common. This thesis shows that a more personalized approach to tricyclic antidepressant (TCA) treatment can improve clinical outcomes. The findings demonstrate substantial variation in current prescribing and dosing practices. Personalized dosing strategies, such as dosing guided by genetic characteristics or early plasma concentrations, enable faster attainment of therapeutic doses and are associated with fewer adverse effects. In addition, specific pharmacological characteristics, including the ratio between active metabolites, are linked to improved effectiveness and tolerability. Early clinical signals, such as improvement in sleep during the first weeks of treatment, also predict later treatment response. Together, these results indicate that tailoring antidepressant treatment to the individual patient can make depression treatment safer and more effective.","Radboud University, 23 maart 2026","Promotores : Schellekens, A.F.A., Aarnoutse, R.E. Co-promotores : Janzing, J.G.E., Coenen, M.J.H.","231 p."],"dc:identifier":["https://hdl.handle.net/2066/329120","9789462843370","Donders Series ; 783,"],"dc:publisher":["S.l. : s.n."],"dc:subject":["Donders Series","Psychiatry - Radboud University Medical Center - DCMN"],"dc:title":["Personalizing tricyclic antidepressant treatment for major depressive disorder"],"dc:type":["Doctoral thesis"]},"updated_at":"2026-07-24T04:03:13Z"}